Early identification of glioma prognostic characteristics is of great clinical importance. This study aims to evaluate the feasibility of APT in the prediction of tumor grade, IDH mutation and MGMT promoter methylation status at 3 Tesla. A total of 50 patients were recruited. Results show that although APTw effect exhibits no substantial difference based on MGMT methylation status, it enables the discrimination of histopathological grade and IDH mutant status with AUCs higher than 0.88. The results suggest APTw is a valuable imaging biomarker for prediction of tumor prognostic parameters, that may benefit accurate diagnosis and prompt treatment decisions.